Akèy › Glomeruloskleroz fokal segmantè › Texas
Etid klinik pou Glomeruloskleroz fokal segmantè nan Texas
5 etid pou Glomeruloskleroz fokal segmantè ap chèche patisipan nan sit nan Texas.
Vil nan Texas
Tèks ofisyèl etid la (Anglè)
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #5, Arlington
- Investigator Site #21, Dallas
- Investigator Site #9, Dallas
- ak 1 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07268638A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
- Texas Tech University Health Sciences Center-Amarillo-63885, Amarillo
- The Healing Kidneys Institute, Conroe
- Advanced Dallas Hospital and Clinics, Dallas
- ak 4 plis
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07220083A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- Renal Disease Research Institute - Dallas - Live Oak Street- Site Number : 8400024, Dallas
- El Paso Kidney Specialists- Site Number : 8400005, El Paso
- Prolato Clinical Research Center- Site Number : 8400016, Houston
Ap rekriteFaz 2
Laj 16 a 75 · Tout sèks · Mizajou Sep 23, 2026 · NCT06500702Nephrotic Syndrome Study Network
- University of Texas-Southwestern, Dallas
- Texas Children's Hospital - Baylor College of Medicine, Houston
Ap rekriteEtid obsèvasyon
Jiska laj 80 · Tout sèks · Mizajou Jun 10, 2026 · NCT01209000Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Texas Children's Hospital, Houston
Ap rekriteFaz 2
Laj 1 a 17 · Tout sèks · Mizajou May 12, 2026 · NCT05003986Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.